Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,461 | 137,917 | 253,256 | 287,166 | 212,499 |
| Marketable Securities | 110,583 | 128,593 | 140,915 | 140,368 | 138,672 |
| Receivables | 83,183 | 83,334 | 75,347 | 85,091 | 103,353 |
| Inventories | 25,179 | 29,664 | 26,691 | 27,953 | 30,674 |
| Other current assets | 0 | 0 | 10,000 | 0 | 77,161 |
| TOTAL | $393,955 | $420,075 | $525,170 | $553,760 | $574,824 |
| Non-Current Assets | |||||
| PPE Net | 8,224 | 8,995 | 7,521 | 7,047 | 7,340 |
| Intangibles | 614,302 | 635,603 | 639,546 | 653,260 | 684,205 |
| Other Non-Current Assets | 7,719 | 8,178 | 3,222 | 1,749 | 561,049 |
| TOTAL | $630,245 | $652,776 | $650,289 | $662,056 | $1,252,594 |
| Total Assets | $1,024,200 | $1,072,851 | $1,175,459 | $1,215,816 | $1,827,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,946 | 21,535 | 14,487 | 30,331 | 10,738 |
| Accrued Expenses | 214,211 | 155,687 | 129,537 | 141,753 | 194,053 |
| Other current liabilities | 128 | 118 | 144 | 208 | 53,172 |
| TOTAL | $246,302 | $182,981 | $165,444 | $193,291 | $278,872 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 466,906 |
| Deferred Revenues | 1,128 | 2,112 | N/A | N/A | 182 |
| Other Non-Current Liabilities | 273,220 | 270,863 | 263,360 | 260,279 | 354,736 |
| TOTAL | $278,391 | $275,151 | $263,360 | $260,279 | $821,642 |
| Total Liabilities | $524,693 | $458,132 | $428,804 | $453,570 | $1,100,514 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,901 | 33,767 | 34,713 | 34,536 | 34,473 |
| Common Shares | 339 | 337 | 346 | 345 | 344 |
| Retained earnings | -785,353 | -664,526 | -542,442 | -520,165 | -551,003 |
| Other shareholders' equity | -3,032 | -3,376 | -3,985 | -4,161 | -4,295 |
| TOTAL | $499,507 | $614,719 | $746,655 | $762,246 | $726,904 |
| Total Liabilities And Equity | $1,024,200 | $1,072,851 | $1,175,459 | $1,215,816 | $1,827,418 |